Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.

Mirza S, Sharma G, Parshad R, Srivastava A, Gupta SD, Ralhan R.

Ann Surg Oncol. 2012 Sep;19(9):3107-15. doi: 10.1245/s10434-012-2323-5. Epub 2012 Mar 27.

PMID:
22451234
[PubMed - indexed for MEDLINE]
2.

Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.

Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R.

Life Sci. 2007 Jul 4;81(4):280-7. Epub 2007 May 25.

PMID:
17599361
[PubMed - indexed for MEDLINE]
3.

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.

PMID:
20470789
[PubMed - indexed for MEDLINE]
4.

Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients.

Shukla S, Mirza S, Sharma G, Parshad R, Gupta SD, Ralhan R.

Epigenetics. 2006 Apr-Jun;1(2):88-93. Epub 2006 Mar 7.

PMID:
17998817
[PubMed - indexed for MEDLINE]
Free Article
5.

Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.

Karray-Chouayekh S, Trifa F, Khabir A, Boujelbane N, Sellami-Boudawara T, Daoud J, Frikha M, Jlidi R, Gargouri A, Mokdad-Gargouri R.

J Cancer Res Clin Oncol. 2010 Feb;136(2):203-10. doi: 10.1007/s00432-009-0649-6. Epub 2009 Aug 6.

PMID:
19657672
[PubMed - indexed for MEDLINE]
6.

Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Tumour Biol. 2011 Feb;32(1):23-32. doi: 10.1007/s13277-010-0087-8. Epub 2010 Aug 10.

PMID:
20697987
[PubMed - indexed for MEDLINE]
7.

Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.

Bagadi SA, Prasad CP, Kaur J, Srivastava A, Prashad R, Gupta SD, Ralhan R.

Life Sci. 2008 Jun 20;82(25-26):1288-92. doi: 10.1016/j.lfs.2008.04.020. Epub 2008 May 11.

PMID:
18538349
[PubMed - indexed for MEDLINE]
8.

Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.

Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.

Clin Cancer Res. 2008 May 1;14(9):2664-72. doi: 10.1158/1078-0432.CCR-07-1232.

PMID:
18451230
[PubMed - indexed for MEDLINE]
Free Article
9.

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.

Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, Sakai A, Ishihara H, Tamaki Y, Noguchi S.

Breast Cancer Res Treat. 2012 Feb;132(1):165-73. doi: 10.1007/s10549-011-1575-2. Epub 2011 May 19.

PMID:
21594664
[PubMed - indexed for MEDLINE]
10.

Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.

Mirza S, Sharma G, Parshad R, Srivastava A, Gupta SD, Ralhan R.

Clin Biochem. 2010 Mar;43(4-5):380-6. doi: 10.1016/j.clinbiochem.2009.11.016. Epub 2009 Dec 1.

PMID:
19961842
[PubMed - indexed for MEDLINE]
11.

[Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].

Zhang JJ, Ouyang T, Wan WH, Xu GW, Deng GR.

Ai Zheng. 2007 Jan;26(1):44-7. Chinese.

PMID:
17222366
[PubMed - indexed for MEDLINE]
12.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

PMID:
19221469
[PubMed - indexed for MEDLINE]
Free Article
13.

CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.

Jing F, Yuping W, Yong C, Jie L, Jun L, Xuanbing T, Lihua H.

Tumour Biol. 2010 Aug;31(4):321-31. doi: 10.1007/s13277-010-0040-x. Epub 2010 May 20.

PMID:
20490964
[PubMed - indexed for MEDLINE]
14.

Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.

Miladi-Abdennadher I, Abdelmaksoud-Damak R, Ayadi L, Khabir A, Frikha F, Kallel L, Amouri A, Frikha M, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R.

Tumour Biol. 2010 Oct;31(5):503-11. doi: 10.1007/s13277-010-0063-3. Epub 2010 Jun 23.

PMID:
20571967
[PubMed - indexed for MEDLINE]
15.

The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.

Pirouzpanah S, Taleban FA, Atri M, Abadi AR, Mehdipour P.

Cancer Causes Control. 2010 Dec;21(12):2101-11. doi: 10.1007/s10552-010-9629-z. Epub 2010 Aug 15.

PMID:
20711807
[PubMed - indexed for MEDLINE]
16.

Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.

Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S, Ralhan R.

Cell Oncol. 2009;31(6):487-500. doi: 10.3233/CLO-2009-0507.

PMID:
19940364
[PubMed - indexed for MEDLINE]
17.

Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.

Kim GE, Lee KH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH.

Virchows Arch. 2011 Oct;459(4):383-90. doi: 10.1007/s00428-011-1143-5. Epub 2011 Sep 6.

PMID:
21894562
[PubMed - indexed for MEDLINE]
18.

Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.

Fujita N, Nakayama T, Yamamoto N, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Morimoto K, Tamaki Y, Noguchi S.

Oncology. 2012;83(5):273-82. doi: 10.1159/000342083. Epub 2012 Sep 5.

PMID:
22964822
[PubMed - indexed for MEDLINE]
19.

Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.

Karray-Chouayekh S, Trifa F, Khabir A, Sellami-Boudawara T, Frikha M, Gargouri A, Mokdad-Gargouri R.

Histol Histopathol. 2012 Mar;27(3):377-85.

PMID:
22237715
[PubMed - indexed for MEDLINE]
20.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

PMID:
15448006
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk